# CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy

Review · Ryuma Tokunaga, Wu Zhang, Madiha Naseem, Alberto Puccini, Martin D. Berger, Shivani Soni, Michelle McSkane, Hideo Baba, Heinz‐Josef Lenz

- Archive id: doi:10.1016/j.ctrv.2017.11.007
- Published: 2017-11-26
- Venue: Cancer Treatment Reviews
- DOI: https://doi.org/10.1016/j.ctrv.2017.11.007
- PMID: 29207310
- Citations: 1,625
- Source URL: https://doi.org/10.1016/j.ctrv.2017.11.007
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.